-+ 0.00%
-+ 0.00%
-+ 0.00%

Enorama Pharma Agrees to Repay DS Global Loans and Accrued Interest in Shares at Maturity

PUBT·11/17/2026 07:51:01
Listen to the news
Enorama Pharma Agrees to Repay DS Global Loans and Accrued Interest in Shares at Maturity
  • Enorama Pharma agreed on Nov. 13, 2026, to repay existing DS Global loans, including interest, with newly issued shares at maturity.
  • The conversion price is SEK 0.4 per share, using an exchange rate of SEK 10 per USD 1.
  • A new USD 2.5 million loan from DS Global is repayable in newly issued shares on Dec. 31, 2027.
  • Shareholders will vote Dec. 4, 2026, on introducing 9% annual interest on the currently interest-free new loan, effective that day.
  • All loans may be repaid early in cash; conversion of the existing loans could raise DS Global's shareholding above 30%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enorama Pharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202611170250BITN____UKPR__SV_20261117-BIT-0140-0) on November 17, 2026, and is solely responsible for the information contained therein.